<code id='889A9D99F0'></code><style id='889A9D99F0'></style>
    • <acronym id='889A9D99F0'></acronym>
      <center id='889A9D99F0'><center id='889A9D99F0'><tfoot id='889A9D99F0'></tfoot></center><abbr id='889A9D99F0'><dir id='889A9D99F0'><tfoot id='889A9D99F0'></tfoot><noframes id='889A9D99F0'>

    • <optgroup id='889A9D99F0'><strike id='889A9D99F0'><sup id='889A9D99F0'></sup></strike><code id='889A9D99F0'></code></optgroup>
        1. <b id='889A9D99F0'><label id='889A9D99F0'><select id='889A9D99F0'><dt id='889A9D99F0'><span id='889A9D99F0'></span></dt></select></label></b><u id='889A9D99F0'></u>
          <i id='889A9D99F0'><strike id='889A9D99F0'><tt id='889A9D99F0'><pre id='889A9D99F0'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:84
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Will an HIV vaccine ever be a reality?
          Will an HIV vaccine ever be a reality?

          LabworkattheAIDSVaccineDesignandDevelopmentLaboratoryinBrooklyn.ChrisHondros/GettyImagesLouisPickeri

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          The stability of $0 premiums in Medicare Advantage

          PabloMartinezMonsivais/APYou’rereadingthewebeditionofHealthCareInc.,STAT’sweeklynewsletterfollowingt